H.C. Wainwright analyst Heiko Ihle raised the firm’s price target on DRDGold (DRD) to $17.25 from $13.25 and keeps a Buy rating on the shares.

H.C. Wainwright raised the firm’s price target on ArriVent Biopharma (AVBP) to $39 from $36 and keeps a Buy rating on the shares after the ...

Immunic Inc (IMUX) stock saw a modest uptick, ending the day at $0.95 which represents no change from the prior close of of $0.95. The stock opened at $0.98 and touched a low of $0.92 during the day, ...

HC Wainwright restated their buy rating on shares of Vanda Pharmaceuticals (NASDAQ:VNDA – Free Report) in a research report released on Tuesday,Benzinga reports. They currently have a $18.00 price ...

BTCS Inc. (Nasdaq: BTCS) (“BTCS” or the“Company”), a leader in blockchain infrastructure and technology, has announced its ...

HC Wainwright reaffirmed their buy rating on shares of Anavex Life Sciences (NASDAQ:AVXL – Free Report) in a report issued on Tuesday morning,Benzinga reports. HC Wainwright currently has a $42.00 ...

Inc. (NASDAQ: IRON) (Disc), a clinical-stage biopharmaceutical company focused on the discovery, development, and ...

Applied DNA Sciences Inc (APDN) stock saw a decline, ending the day at $0.18 which represents a decrease of $-0.01 or -5.26% from the prior close of $0.19. The stock opened at $0.19 and touched a low ...

SAN DIEGO, CA / ACCESS Newswire / January 22, 2025 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata," or ...

Despite a 15% drop in the SPDR S&P Biotech ETF, insider buying presents opportunities. Read why these small and mid-cap ...

Lily Cheung, the Chief Human Resource Officer at Pliant Therapeutics, Inc. (NASDAQ:PLRX), recently sold shares of the company ...

James initiated coverage on Electrovaya Inc. (NASDAQ:ELVA), a Canadian manufacturer specializing in lithium-ion batteries, ...